Christopher J. Senner - Aug 9, 2024 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role
EVP and CFO
Signature
/s/ Nina Ayer, Attorney in Fact
Stock symbol
EXEL
Transactions as of
Aug 9, 2024
Transactions value $
-$347,500
Form type
4
Date filed
8/9/2024, 07:31 PM
Previous filing
Jun 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Options Exercise $3.05M +125K +17.32% $24.41 847K Aug 9, 2024 Direct F1
transaction EXEL Common Stock Sale -$3.4M -125K -14.76% $27.19 722K Aug 9, 2024 Direct F1, F2
holding EXEL Common Stock 2.72K Aug 9, 2024 By 401(k) F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXEL Option (right to buy) Options Exercise $0 -125K -100% $0.00* 0 Aug 9, 2024 Common Stock 125K $24.41 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 272,874 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
F2 Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $27.08 to $27.35. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F3 Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of August 8, 2024.
F4 The option, representing the right to purchase a total of 125,000 shares of Exelixis, Inc. common stock became fully exercisable on October 3, 2021.